LNA Sante

LNA Sante SA Formerly known as Le Noble Age. LNA Sante SA, formerly known as Le Noble Age SA is a France-based company that owns and operates retirement homes and complexes for elderly residents. The Company's residences provide care and assistance for elderly people with a variety of needs, from those with a high level of independence, to those who are completely dependent. LNA Sante SA is also engaged in real estate operations. The Company has residences in France and Belgium. LNA Sante SA operates through its several subsidiaries, including Le Parc de Diane Sarl, Institut Medicalise de Mar Vivo, Gerhome, Residence le Point du Jour and the home healthcare service provider ARAIR Assistance, as well as ARAIR Group's support and training services, among others.
  • TickerLNA
  • ISINFR0004170017
  • ExchangeEuronext Paris
  • SectorHealth Care Equipment & Services
  • CountryFrance

Analysts

With a more favourable environment, LNA SANTE SA improves to Slightly Positive

LNA SANTE SA (FR), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date December 4, 2018, the closing price was EUR 47.55 and its potential was estimated at EUR 54.75.

Baptiste Lebacq ...
  • Christophe-Raphaël Ganet
  • Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 11/20/2018

...

Alfred Glaser ...
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Agnès Hamdani
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Johanna Jourdain
  • Matthias Desmarais
  • Olivier Lebrun
  • Pierre Tegner
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/20/2018

...

Christophe-Raphaël Ganet

Eurofins : Armonéa for sale: read-across

>Armonéa: around 9,000 beds - According to French daily Les Echos, Armonéa one of the three main Belgian operators of retirement homes, is up for sale.Armonéa was created in 2008 and reportedly manages around 85 facilities and approximately 9,000 beds (compared with 7,443 beds for Orpea and 10,761 beds for Korian).The group is thought to generate around € 492m in sales (of which € 365m in Belgium) and € 40m in EBITDA (of which € 26m in Belgium). This gives a...

Alfred Glaser ...
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Agnès Hamdani
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Johanna Jourdain
  • Matthias Desmarais
  • Olivier Lebrun
  • Pierre Tegner
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 20/11/2018

...

Bruno de La Rochebrochard

LNA Santé: Q2 revenue: Ahead our expectation with sustained organic. FY organic now expected over 4%.

Brief Comment - LNA Santé: (BUY, Fair Value EUR68 (+24%)) Q2 revenue: Ahead our expectation with sustained organic. FY organic now expected over 4%.

Christophe-Raphaël Ganet

Eurofins : Armonéa for sale: read-across

>Armonéa: around 9,000 beds - According to French daily Les Echos, Armonéa one of the three main Belgian operators of retirement homes, is up for sale.Armonéa was created in 2008 and reportedly manages around 85 facilities and approximately 9,000 beds (compared with 7,443 beds for Orpea and 10,761 beds for Korian).The group is thought to generate around € 492m in sales (of which € 365m in Belgium) and € 40m in EBITDA (of which € 26m in Belgium). This gives a...

Christophe-Raphaël Ganet

Eurofins : Armonéa à vendre : read-across

>Armonéa : environ 9 000 lits - Selon le quotidien Les Echos, Armonéa, l’un des 3 principaux opérateurs belges de maisons de retraite (maison de repos), créé en 2008, serait en vente.Armonéa gérerait environ 85 établissements et près de 9 000 lits (à comparer à 7 443 lits pour Orpéa et 10 761 lits pour Korian).Le groupe réaliserait près de 492 M€ de CA (dont 365 M€ en Belgique) et 40 M€e d’EBITDA, (dont 26 M€ en Belgique). Soit une marge d’EBITDA de 8,1%.§rc...

Bruno de La Rochebrochard

LNA SANTÉ: Q3 organic revenue growth accelerating. Recently upgraded FY guidance confirmed | BUY | EUR68

LNA SANTÉ - BUY | EUR68(+47%) Q3 organic revenue growth accelerating. Recently upgraded FY guidance confirmed Sustained Q3 revenue with organic again accelerating Confirmation of FY guidance, revised upwards after H1 results

Christophe-Raphaël Ganet

LNA Santé : Solid Q3 2018 revenues (5.1% l-f-l) confirming the guidance for full-year growth of over 4% l-f-l

>Q3: +5.1% organic, slightly better thanks to home care in particular - Q3 operating revenues came to € 110.2m, up 6.4% (+5.1% at constant scope with +2.3% for volumes, +2.8% from the price-mix and 1.3% from acquisitions). LNA did not see any significant openings in Q3.In the first nine months, revenues came to € 324.3m, an increase of 5.5% versus 2017, with 4.4% organic growth.Facilities at cruising speed represent 6,163 beds, or 85% of the total in operati...

Christophe-Raphaël Ganet

LNA Santé : CA T3 2018 solide (5,1% lfl.) validant la guidance annuelle à plus de 4% lfl.

>T3: +5,1% organique, un peu meilleure grâce à l’HAD notamment - Le CA Exploitation du T3 s’est monté à 110,2 M€, en hausse de 6,4% (+5,1% à pc. dont +2,3% volume et +2,8% de prix-mix et 1,3% de croissance externe). Au T3, LNA n’a pas connu de mouvement d’ouverture significatif.Sur les 9 premiers mois, le CA s'établit à 324,3 M€, en progression de 5,5% par rapport à 2017, dont 4,4% organique.Les établissements en régime de croisière représentent 6 163 lits, ...

1 director sold

A director at Lna Sante Sa sold 500 shares at 55.178EUR and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board memb...

Baptiste Lebacq ...
  • Christophe-Raphaël Ganet
  • Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 11/20/2018

...

Alfred Glaser ...
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Agnès Hamdani
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Johanna Jourdain
  • Matthias Desmarais
  • Olivier Lebrun
  • Pierre Tegner
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 11/20/2018

...

Alfred Glaser ...
  • Christophe-Raphaël Ganet
  • Delphine Brault
  • Fatma Agnès Hamdani
  • François Maury
  • Georges Dieng
  • Jean Sassus
  • Johanna Jourdain
  • Matthias Desmarais
  • Olivier Lebrun
  • Pierre Tegner
  • Steven Gould
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 20/11/2018

...

Baptiste Lebacq ...
  • Christophe-Raphaël Ganet
  • Jerôme Bodin

ODDO BHF Small & MIDCAP MORNING NEWS - 20/11/2018

...

Charles Lepetitpas ...
  • Christophe-Raphaël Ganet
  • Harold De Decker
  • Jean-François Granjon
  • Jeremy Garnier
  • Jerôme Bodin
  • Léopold Authié
  • Sven Edelfelt
  • Virginie Rousseau

ODDO BHF Small & MIDCAP MORNING NEWS - 11/07/2018

...

With a more favourable environment, LNA SANTE SA improves to Slightly Positive

LNA SANTE SA (FR), a company active in the Health Care Providers industry, is favoured by a more supportive environment. The independent financial analyst theScreener has confirmed the fundamental rating of the title, which shows 3 out of 4 stars, as well as its unchanged, moderately risky market behaviour. The title leverages a more favourable environment and raises its general evaluation to Slightly Positive. As of the analysis date December 4, 2018, the closing price was EUR 47.55 and its potential was estimated at EUR 54.75.

Ford Equity International Rating and Forecast Report

Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week...

Jehanne Leroy

Proxy Report - 20/06/2018

Parmi les résolutions proposées par la société, six portent sur la rémunération des dirigeants. Même si les montants indiqués semblentraisonnables, l'absence de communication du bonus annuel total ne nous permet pas de les soutenir (résolutions 10 à 15). En raison de montants demandés trop élevés et de la possibilité d'utilisation en période d'o?re publique, la majorité des autorisations d'augmentation de capital demandées sera refusée (résolutions 18 à 21 et 23 et 24).

SRI Quantitative KPIs

Les analyses Gaïa sont des analyses ESG (Environnement, Social, Gouvernance) dediees aux entreprises de tailles intermediaires (PME, ETI) françaises. Elles presentent 120 indicateurs quantitatifs sur les trois derniers exercices.

SRI Company Analysis

Geol analyses are ESG (Environment, Social, Governance) analyses covering European large caps and small and mid caps, listed or non-listed. Those analyses, based on the ESG risks identified, show the qualitative and quantitative performance of issuers, in a ten-page synthesis.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch